Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating testosterone replacement therapy as an adjunctive ERAS strategy in male patients with end-stage renal di…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury
Clinical trial update on testosterone deficiency and endothelial dysfunction after spinal cord injury. The study is currently recruiting.
-
FDA approval · 2025-10-15FDA Approved: ESTROGENS, CONJUGATED — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved the original application for a generic conjugated estrogens product from Ingenus Pharmaceuticals, LLC, marking entry of this ge…
-
FDA approval · 2025-09-12FDA Approved: JATENZO — Supplemental Application (TOLMAR Inc.)
The FDA approved Tolmar Inc.'s supplemental application for JATENZO (testosterone undecanoate).
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months [Phase 4]
This is a Phase 4 trial update examining adrenal function in hypogonadal men treated with JATENZO for 12 months; the study is currently ACTI…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Adaptions and Resiliency to Multi-Stressor OpeRations [Phase 4]
A Phase 4 clinical trial update recruiting participants for conditions of musculoskeletal injuries and hypogonadism.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
A clinical trial investigating late subclinical cardiovascular disease in testicular cancer survivors has been terminated.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
This clinical trial update reports recruitment for evaluating sex steroid replacement therapy in individuals with hypogonadism and gender dy…
-
FDA approval · 2025-07-21FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Alvogen Inc.)
FDA approved a supplemental application for Testosterone Cypionate from Alvogen Inc., under ANDA207742.
-
FDA approval · 2025-07-15FDA Approved: TESTOSTERONE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for testosterone submitted by Actavis Pharma, Inc., authorizing changes to the product under an …
-
FDA label_change · 2025-07-11FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Hospira, Inc.)
FDA approves a supplemental application for TESTOSTERONE CYPIONATE (Hospira, Inc.), resulting in labeling changes for this testosterone repl…
-
FDA approval · 2025-07-11FDA Approved: TESTIM — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for TESTIM (testosterone) submitted by Endo USA, Inc.
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for TESTOSTERONE, updating labeling for the generic testosterone product.
-
FDA approval · 2025-07-11FDA Approved: JATENZO — Supplemental Application (TOLMAR Inc.)
FDA approved a supplemental application for JATENZO (testosterone undecanoate) from Tolmar Inc., signaling an approval of a change to the ND…
-
FDA approval · 2025-07-11FDA Approved: XYOSTED — Supplemental Application (Antares Pharma, Inc.)
FDA approved a supplemental application for XYOSTED (testosterone enanthate) from Antares Pharma, Inc.
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for TESTOSTERONE from Cipla USA Inc. under an ANDA.
-
FDA approval · 2025-07-11FDA Approved: TLANDO — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TLANDO (testosterone undecanoate) submitted by Verity Pharmaceuticals Inc.
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for TESTOSTERONE CYPIONATE submitted by Padagis US LLC. The approval confirms marketing authorizatio…
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE ENANTHATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for testosterone enanthate from Hikma Pharmaceuticals USA Inc. This action updates the regulatory st…
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical's testosterone cypionate, enabling continued marketing of the generic testost…
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approves a supplemental application for TESTOSTERONE by Alembic Pharmaceuticals Inc., authorizing changes to the product's labeling.
-
FDA approval · 2025-07-11FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for testosterone cypionate by Padagis US LLC. The document confirms regulatory action on the product…
-
FDA approval · 2025-07-11FDA Approved: AZMIRO — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZMIRO (testosterone cypionate) from Azurity Pharmaceuticals, Inc.
-
FDA approval · 2025-07-11FDA Approved: METHITEST — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for METHITEST (methyltestosterone) from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2025-07-11FDA Approved: ANDROGEL — Supplemental Application (ASCEND Therapeutics U.S., LLC)
FDA approved a supplemental application for ANDROGEL (testosterone) submitted by ASCEND Therapeutics U.S., LLC.